article Open access
SARS-CoV, MERS-CoV and now the 2019-novel CoV: Have we investigated enough about coronaviruses? – A bibliometric analysis
D. Katterine Bonilla‐Aldanaa b, Keidenís Quintero-Radaa, Juan Pablo Montoya-Posadaa, Sebastián Ramírez-Ocampob, Alberto Paniz‐Mondolfic d e f, Ali Ahmed Rabaang, Ranjit Sahh, Alfonso Javier Rodriguez-Moralesb i j✉
- aSemillero de Investigación en Zoonosis, Grupo de Investigación BIOECOS, Fundación Universitaria Autónoma de las Américas, Pereira, Risaralda, Colombia
- bPublic Health and Infection Research and Incubator Group, Faculty of Health Sciences, Universidad Tecnológica de Pereira, Pereira, Risaralda, Colombia
- cLaboratory of Medical Microbiology, Department of Pathology, Molecular and Cell-based Medicine, The Mount Sinai Hospital-Icahn School of Medicine at Mount Sinai, New York, USA
- dLaboratorio de Señalización Celular y Bioquímica de Parásitos, Instituto de Estudios Avanzados (IDEA), Caracas, Caracas, Venezuela
- eAcademia Nacional de Medicina, Caracas, Venezuela
- fInstituto de Investigaciones Biomedicas IDB / Incubadora Venezolana de la Ciencia, Cabudare, Edo. Lara, Venezuela
- gMolecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia
- hDepartment of Microbiology, Tribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepal
Looking for the full paper…
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
No abstract is available from our sources. Use “Read paper” to view it.
TL;DRA large scale docking analysis using 7900 drug candidates and 20 Dihydroorotate dehydrogenase structures identifies 28-FDA approved candidate molecules and shows common characteristics among the candidates, especially their association with serotonin-dopamine receptors. (Semantic Scholar)